Abstract
Pitt-Hopkins syndrome (PTHS, MIM #610954) is characterized by severe intellectual disability, typical facial features and tendency to epilepsy, panting-and-holding breathing anomaly, stereotypic movements, constipation, and high myopia. Growth is normal or only mildly retarded, but half of the patients have postnatal microcephaly. Remarkably, congenital malformations are practically nonexistent. The cause of PTHS is de novo haploinsufficiency of the TCF4 gene (MIM *602272) at 18q21.2. Altogether 78 PTHS patients with abnormalities of the TCF4 gene have been published since 2007 when the etiology of PTHS was revealed. In addition, 27 patients with 18q deletion encompassing the TCF4 gene but without given PTHS diagnosis have been published, and thus, the number of reported patients with a TCF4 abnormality exceeds 100. The mutational spectrum includes large chromosomal deletions encompassing the whole TCF4 gene, partial gene deletions, frameshift (including premature stop codon), nonsense, splice site, and missense mutations. So far, almost all patients have a private mutation and only 2 recurrent mutations are known. There is no evident genotype-phenotype correlation. No familial cases have been reported. Diagnosis of PTHS is based on the molecular confirmation of the characteristic clinical features. Recently, a Pitt-Hopkins-like phenotype has been assigned to autosomal recessive mutations of the CNTNAP2 gene at 7q33q36 and the NRXN1 gene at 2p16.3.
References
1.
Amiel J, Rio M, de Pontual L, Redon R, Malan V, et al: Mutations in TCF4, encoding a class I basic helix-loop-helix transcription factor, are responsible for Pitt-Hopkins syndrome, a severe epileptic encephalopathy associated with autonomic dysfunction. Am J Hum Genet 80:988–993 (2007).
2.
Andrieux J, Lepretre F, Cuisset JM, Goldenberg A, Delobel B, et al: Deletion 18q21.2q21.32 involving TCF4 in a boy diagnosed by CGH-array. Eur J Med Genet 51:172–177 (2008).
3.
Blake DJ, Forrest M, Chapman RM, Tinsley CL, O’Donovan MC, Owen MJ: TCF4, schizophrenia, and Pitt-Hopkins Syndrome. Schizophr Bull 36:443–447 (2010).
4.
Brockschmidt A, Todt U, Ryu S, Hoischen A, Landwehr C, et al: Severe mental retardation with breathing abnormalities (Pitt-Hopkins syndrome) is caused by haploinsufficiency of the neuronal bHLH transcription factor TCF4. Hum Mol Genet 16:1488–1494 (2007).
5.
Brockschmidt A, Filippi A, Charbel Issa P, Nelles M, Urbach H, et al: Neurologic and ocular phenotype in Pitt-Hopkins syndrome and a zebrafish model. Hum Genet 130:645–655 (2011).
6.
Brzózka MM, Radyushkin K, Wichert SP, Ehrenreich H, Rossner MJ: Cognitive and sensorimotor gating impairments in transgenic mice overexpressing the schizophrenia susceptibility gene Tcf4 in the brain. Biol Psychiatry 68:33–40 (2010).
7.
Cisse B, Caton ML, Lehner M, Maeda T, Scheu S, et al: Transcription factor E2–2 is an essential and specific regulator of plasmacytoid dendritic cell development. Cell 135:37–48 (2008).
8.
Corneliussen B, Thornell A, Hallberg B, Grundström T: Helix-loop-helix transcriptional activators bind to a sequence in glucocorticoid response elements of retrovirus enhancers. J Virol 65: 6084–6093 (1991).
9.
Flora A, Garcia JJ, Thaller C, Zoghbi HY: The E-protein Tcf4 interacts with Math1 to regulate differentiation of a specific subset of neuronal progenitors. Proc Natl Acad Sci USA 104:15382–15387 (2007).
10.
de Pontual L, Mathieu Y, Golzio C, Rio M, Malan V, et al: Mutational, functional, and expression studies of the TCF4 gene in Pitt-Hopkins syndrome. Hum Mutat 30:669–676 (2009).
11.
Giurgea I, Missirian C, Cacciagli P, Whalen S, Fredriksen T, et al: TCF4 deletions in Pitt-Hopkins Syndrome. Hum Mutat 29:E242–E251 (2008).
12.
Guillemot F, Lo LC, Johnson JE, Auerbach A, Anderson DJ, Joyner AL: Mammalian achaete-scute homolog 1 is required for the early development of olfactory and autonomic neurons. Cell 75:463–476 (1993).
13.
Hasi M, Soileau B, Sebold C, Hill A, Hale DE, et al: The role of the TCF4 gene in the phenotype of individuals with 18q segmental deletions. Hum Genet 130:777–787 (2011).
14.
Heard PL, Carter EM, Crandall AC, Sebold C, Hale DE, Cody JD: High resolution genomic analysis of 18q- using oligo-microarray comparative genomic hybridization (aCGH). Am J Med Genet A 149A:1431–1437 (2009).
15.
Kalscheuer VM, Feenstra I, Van Ravenswaaij-Arts CM, Smeets DF, Menzel C, et al: Disruption of the TCF4 gene in a girl with mental retardation but without the classical Pitt-Hopkins syndrome. Am J Med Genet A 146A:2053–2059 (2008).
16.
Kato Z, Morimoto W, Kimura T, Matsushima A, Kondo N: Interstitial deletion of 18q: comparative genomic hybridization array analysis of 46,XX,del(18)(q21.2.q21.33). Birth Defects Res A Clin Mol Teratol 88:132–135 (2010).
17.
Lehalle D, Williams C, Siu VM, Clayton-Smith J: Fetal pads as a clue to the diagnosis of Pitt-Hopkins syndrome. Am J Med Genet A 155A:1685–1689 (2011).
18.
Lennertz L, Rujescu D, Wagner M, Frommann I, Schulze-Rauschenbach S, et al: Novel schizophrenia risk gene TCF4 influences verbal learning and memory functioning in schizophrenia patients. Neuropsychobiology 63:131–136 (2011).
19.
Marangi G, Ricciardi S, Orteschi D, Lattante S, Murdolo M, et al: The Pitt-Hopkins syndrome: report of 16 new patients and clinical diagnostic criteria. Am J Med Genet A 155A:1536–1545 (2011).
20.
Orrico A, Galli L, Zappella M, Lam CW, Bonifacio S, et al: Possible case of Pitt-Hopkins syndrome in sibs. Am J Med Genet 103:157–159 (2001).
21.
Peippo MM, Simola KO, Valanne LK, Larsen AT, Kähkönen M, et al: Pitt-Hopkins syndrome in two patients and further definition of the phenotype. Clin Dysmorphol 15:47–54 (2006).
22.
Pitt D, Hopkins I: A syndrome of mental retardation, wide mouth and intermittent overbreathing. Aust Paediatr J 14:182–184 (1978).
23.
Pitt D, Roboz P: A survey of 782 cases of mental deficiency. J Ment Defic Res 9:4–23 (1965).
24.
Pscherer A, Dörflinger U, Kirfel J, Gawlas K, Rüschoff J, et al: The helix-loop-helix transcription factor SEF-2 regulates the activity of a novel initiator element in the promoter of the human somatostatin receptor II gene. EMBO J 15:6680–6690 (1996).
25.
Quednow BB, Ettinger U, Mössner R, Rujescu D, Giegling I, et al: The schizophrenia risk allele C of the TCF4 rs9960767 polymorphism disrupts sensorimotor gating in schizophrenia spectrum and healthy volunteers. J Neurosci 31:6684–6691 (2011).
26.
Rosenfeld JA, Leppig K, Ballif BC, Thiese H, Erdie-Lalena C, et al: Genotype-phenotype analysis of TCF4 mutations causing Pitt-Hopkins syndrome shows increased seizure activity with missense mutations. Genet Med 11:797–805 (2009).
27.
Shirasawa S, Arata A, Onimaru H, Roth KA, Brown GA, et al: Rnx deficiency results in congenital central hypoventilation. Nat Genet 24:287–290 (2000).
28.
Singh HA: Mental retardation, macrostomia and hyperpnoea syndrome. J Paediatr Child Health 29:156–157 (1993).
29.
Stavropoulos DJ, MacGregor DL, Yoon G: Mosaic microdeletion 18q21 as a cause of mental retardation. Eur J Med Genet 53:396–399 (2010).
30.
Taddeucci G, Bonuccelli A, Mantellassi I, Orsini A, Tarantino E: Pitt-Hopkins syndrome: report of a case with a TCF4 gene mutation. Ital J Pediatr 36:12 (2010).
31.
Takano K, Lyons M, Moyes C, Jones J, Schwartz CE: Two percent of patients suspected of having Angelman syndrome have TCF4 mutations. Clin Genet 78:282–288 (2010).
32.
Van Balkom ID, Quartel S, Hennekam RC: Mental retardation, ‘coarse’ face, and hyperbreathing: confirmation of the Pitt-Hopkins syndrome. Am J Med Genet 75:273–276 (1998).
33.
Wilson MG, Towner JW, Forsman I, Siris E: Syndromes associated with deletion of the long arm of chromosome 18[del(18q)]). Am J Med Genet 3:155–174 (1979).
34.
Zhuang Y, Cheng P, Weintraub H: B-lymphocyte development is regulated by the combined dosage of three basic helix-loop-helix genes, E2A, E2–2, and HEB. Molec Cell Biol 16:2898–2905 (1996).
35.
Zweier C, Peippo MM, Hoyer J, Sousa S, Bottani A, et al: Haploinsufficiency of TCF4 causes syndromal mental retardation with intermittent hyperventilation (Pitt-Hopkins syndrome). Am J Hum Genet 80:994–1001 (2007).
36.
Zweier C, Sticht H, Bijlsma EK, Clayton-Smith J, Boonen SE, et al: Further delineation of Pitt-Hopkins syndrome: phenotypic and genotypic description of 16 novel patients. J Med Genet 45:738–744 (2008).
37.
Zweier C, de Jong EK, Zweier M, Orrico A, Ousager LB, et al: CNTNAP2 and NRXN1 are mutated in autosomal-recessive Pitt-Hopkins-like mental retardation and determine the level of a common synaptic protein in Drosophila. Am J Hum Genet 85:655–666 (2009).
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
